Radionuclide carriers for targeting of cancer

References

• AdamMJWilburDSRadiohalogens for imaging and therapyChem Soc Rev2005341536315672179
   PubMed Web of Science ®Google Scholar
• AdamsGPSchierRMcCallAMHigh affinity restricts the localization and tumor penetration of single-chain Fv antibody moleculesCancer Res2001614750511406547
   PubMed Web of Science ®Google Scholar
• AlessiPEbbinghausCNeriDMolecular targeting of angiogenesisBiochim Biophys Acta20041654394914984766
   PubMed Web of Science ®Google Scholar
• AllenBRajaCRizviSTumour anti-vascular alpha therapy: a mechanism for the regression of solid tumours in metastatic cancerPhys Med Biol200752L15917664565
   PubMed Web of Science ®Google Scholar
• AllenCDos SantosNGallagherRControlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol)Bioscience Rep20022222550
   PubMed Web of Science ®Google Scholar
• AllenTMLigand-targeted therapeutics in anticancer therapyNature Cancer Rev2002275063
   PubMed Web of Science ®Google Scholar
• AugusteDTPrud’hommeRKAhlPLAssociation of hydrophobically-modified poly(ethylene glycol) with fusogenic liposomesBiochim Biophys Acta200316161849514561476
   PubMed Web of Science ®Google Scholar
• AzabA-KSrebnikMDovinerVTargeting normal and neoplastic tissues in the rat jejunum and colon with boronated, cationic acrylamide copolymersJ Control Release2005106142516005094
   PubMed Web of Science ®Google Scholar
• BakerMVGaynutdinovTIPatelVVascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculatureMol Cancer Ther200541423916170035
   PubMed Web of Science ®Google Scholar
• BarthRFAdamsDMSolowayAHBoronated starburst dendrimer-monoclonal antibody imunoconjugates: evaluation as a potential delivery system for neutron capture therapyBioconjugate Chem199455866
   PubMed Web of Science ®Google Scholar
• BethgeWASandmaierBMTargeted cancer therapy using radiolabeled monoclonal antibodiesTechnol Cancer Res Treat2005439340516029058
   PubMed Web of Science ®Google Scholar
• BloomerWDMcLaughlinWHNeirinckxRDAstatine-211—tellurium radiocolloid cures experimental malignant ascitesScience198121234017209534
   PubMed Web of Science ®Google Scholar
• BorchardtPYuanRMiedererMTargeted actinium-225 in vivo generators for therapy of ovarian cancerCancer Res200363508412941838
   PubMed Web of Science ®Google Scholar
• BoswellCABrechbielMWAuger electrons: lethal, low energy, and coming soon to a tumor cell nucleus near youJ Nucl Med2005461946716330556
   PubMed Web of Science ®Google Scholar
• BottaroDPLiottaLACancer: Out of air is not out of actionNature2003423593512789320
   PubMed Web of Science ®Google Scholar
• BrechbielMWBifunctional chelates for metal nuclidesQ J Nucl Med Mol Imaging20071128 Epub ahead of print
   Web of Science ®Google Scholar
• Britz-CunninghamSHAdelsteinSJMolecular targeting with radionuclides: state of the scienceJ Nucl Med20034419456114660721
   PubMed Web of Science ®Google Scholar
• BrooksPCClarkRAChereshDARequirement of vascular integrin alpha v beta 3 for angiogenesisScience1994264569717512751
   PubMed Web of Science ®Google Scholar
• BrueraENeumannCMPituskinEA randomized controlled trial of local injections of hyaluronidase versus placebo in cancer patients receiving subcutaneous hydrationAnn Oncol1999101255810586347
   PubMed Web of Science ®Google Scholar
• BuchsbaumDJChaudhuriTRZinnKRRadiotargeted gene therapyJ Nucl Med2005a46179s86s15653667
   PubMed Web of Science ®Google Scholar
• BuchsbaumDJKhazaeliMAxworthyDBIntraperitoneal pretarget radioimmunotherapy with CC49 fusion proteinClin Cancer Res2005b1581805
   Web of Science ®Google Scholar
• BuijsWCAMTibbenJGBoermanOCDosimetric analysis of chimeric monoclonal antibody cMOv18 IgG in ovarian carcinoma patients after intraperitoneal and intravenous administrationEur J Nucl Med1998251552619799353
   PubMedGoogle Scholar
• BurgMAPasqualiniRArapWNG2 proteoglycan-binding peptides target tumor neovasculatureCancer Res19995928697410383148
   PubMed Web of Science ®Google Scholar
• BurrowsFJThorpePEEradication of large solid tumors in mice with an immunotoxin directed against tumor vasculatureProc Natl Acad Sci USA199390899690007692443
   PubMed Web of Science ®Google Scholar
• CampbellAMBaileyIHBurtonMAAnalysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapyPhys Med Biol20004510233310795989
   PubMed Web of Science ®Google Scholar
• CarmelietPJainRKAngiogenesis in cancer and other diseasesNature20004072495711001068
   PubMed Web of Science ®Google Scholar
• ChunfuZJinquanCDuanzhiYPreparation and radiolabeling of human serum albumin (HSA)-coated magnetite nanoparticles for magnetically targeted therapyAppl Radiat Isot2004611255915388118
   PubMed Web of Science ®Google Scholar
• CouturierOSupiotODegraef-MouginMCancer radioimmunotherapy with alpha-emitting nuclidesEur J Nucl Med Imaging20053260114
   Web of Science ®Google Scholar
• CrippaFBolisGSeregniESingle-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: Clinical results in patients with minimal residual disease of ovarian cancerEur J Cancer199531686907640039
   PubMed Web of Science ®Google Scholar
• DaviesCLLundstromLMFrengenJRadiation improves the distribution and uptake of liposomal Doxorubicin (Caelyx) in human osteosarcoma xenograftsCancer Res2004645475314744768
   PubMed Web of Science ®Google Scholar
• de JongMBreemanWAPBernardBFTumor response after [90Y-DOTA0,Tyr3]Octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor sizeJ Nucl Med2001421841611752083
   PubMed Web of Science ®Google Scholar
• DearlingJLJPedleyRBTechnological advances in radioimmunotherapyClin Oncol20071945769
   Web of Science ®Google Scholar
• del RosarioRBWahlRLBiotinylated iodo-polylysine for pretargeted radiation deliveryJ Nucl Med1993341147518315493
   PubMed Web of Science ®Google Scholar
• DelgadoGPotkulRTreatJA phase I/II study of intraperitoneally administered doxorubicin entrappedAm J of Obs Gyn1989160812
   PubMed Web of Science ®Google Scholar
• DuJMarquezMHiltunenJRadiolabeling of dextran with rhenium-188Appl Radiat Isot200053443810972151
   PubMed Web of Science ®Google Scholar
• DuncanRIzzoLDendrimer biocompatibility and toxicityAdv Drug Deliv Rev20055722153716297497
   PubMed Web of Science ®Google Scholar
• EikenesLBrulandOSBrekkenCCollagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenograftsCancer Res20046447687315256445
   PubMed Web of Science ®Google Scholar
• EikenesLTariMTuftoIHyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (CaelyxTM) in human osteosarcoma xenograftsBr J Cancer20059381815942637
   PubMed Web of Science ®Google Scholar
• EmfietzoglouDKostarelosKPapakostasALiposome-mediated radiotherapeutics within avascular tumor spheroids: comparative dosimetry study for various radionuclides, liposome systems, and a targeting antibodyJ Nucl Med200546899715632038
   PubMed Web of Science ®Google Scholar
• EpenetosAMunroAStewartSAntibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodiesJ Clin Oncol19875189093681374
   PubMed Web of Science ®Google Scholar
• FaraggiGGardinIde Labriolle-VayletCThe influence of tracer localization on the electron dose rate delivered to the cell nucleusJ Nucl Med199435113198271031
   PubMed Web of Science ®Google Scholar
• FeakesDAShellyKKnoblerCBNa3[B20H17NH3]: Synthesis and liposomal delivery to murine tumorsProc Natl Acad Sci USA1994913029338159700
   PubMed Web of Science ®Google Scholar
• FolkmanJTumor angiogenesis: therapeutic implicationsN Engl J Med1971285118264938153
   PubMed Web of Science ®Google Scholar
• FolkmanJWhat is the evidence that tumors are angiogenesis dependent?J Natl Cancer Inst199082461688381
   PubMed Web of Science ®Google Scholar
• GabizonAShmeedaHBarenholzYPharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studiesClin Pharmacokinet2003424193612739982
   PubMed Web of Science ®Google Scholar
• GilliesERFrechetJMJDendrimers and dendritic polymers in drug deliveryDrug Discov Today200510354315676297
   PubMed Web of Science ®Google Scholar
• GoldenbergDMTargeted therapy of cancer with radiolabeled antibodiesJ Nucl Med20024369371311994535
   PubMed Web of Science ®Google Scholar
• GoldenbergDMSharkeyRMPaganelliGAntibody pretargeting advances cancer radioimmunodetection and radioimmunotherapyJ Clin Oncol2006248233416380412
   PubMed Web of Science ®Google Scholar
• HaefeliUOSweeneySMBeresfordBAEffective targeting of magnetic radioactive Yttrium-90 microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo resultsNucl Med Biol199522147557767307
   PubMed Web of Science ®Google Scholar
• HaefeliUOCasillasSDietzDWHepatic tumor radioembolization in a rat model using radioactive rhenium (186Re/188Re) glass microspheresInt J Radiation Oncology Biol Phys19994418999
   Web of Science ®Google Scholar
• HaefeliUOPauerGFailingSRadiolabeling of magnetic particle with rhenium-188 for cancer therapyJ Magn Magn Mater2001225738
   Web of Science ®Google Scholar
• HallahanDShimianQGengLRadiation-mediated control of drug deliveryAm J Clin Oncol2001a244738011586099
   PubMed Web of Science ®Google Scholar
• HallahanDGengLQuSIntegrin-mediated targeting of drug delivery to irradiated tumor blood vesselsCancer Cell20033637412559176
   PubMed Web of Science ®Google Scholar
• HallahanDEGengLCmelakATargeting drug delivery to radiation-induced neoantigens in tumor microvasculatureJ Control Release2001b741839111489494
   PubMed Web of Science ®Google Scholar
• HartmanTCarlssonJRadiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapyRadiother Oncol19943161758041899
   PubMed Web of Science ®Google Scholar
• HawthorneMFShellyKLiposomes as drug delivery vehicles for boron agentsJ Neurooncol1997335389151223
   PubMed Web of Science ®Google Scholar
• HeiTKPersaudRZhouHGenotoxicity in the eyes of bystander cellsMutat Res20045681112015530544
   PubMed Web of Science ®Google Scholar
• HenriksenGBrulandOSLarsenRHThorium- and Actinium polyphosphate compounds as bone-seeking alpha particle emitting agentsAnticancer Res2004a24101515015582
   PubMed Web of Science ®Google Scholar
• HenriksenGSchoultzBWMichaelsenTESterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclidesNucl Med Biol2004b31441915093814
   PubMed Web of Science ®Google Scholar
• HobbsSKMonskyWLYuanFRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironmentPNAS1998954607129539785
   PubMed Web of Science ®Google Scholar
• HobsonBDenekampJEndothelial proliferation in tumours and normal tissues: continuous labelling studiesBr J Cancer198449405136201181
   PubMed Web of Science ®Google Scholar
• HouleSYipT-CKShepherdFAHepatocellular carcinoma: pilot trial of treatment with Yttrium-90 microspheresRadiology1989172857602549567
   PubMed Web of Science ®Google Scholar
• HummJLA microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapyInt J Radiat Oncol Biol Phys1987131767733667382
   PubMedGoogle Scholar
• HummJLChinLMA model of cell inactivation by alpha-particle internal emittersRadiat Res1993134143508488249
   PubMed Web of Science ®Google Scholar
• HwangKJMerriamJEBeaumierPLEncapsulation, with high efficiency, of radioactive metal ions in liposomesBiochim Biophys Acta198271610196807354
   PubMed Web of Science ®Google Scholar
• HynesNELaneHAERBB receptors and cancer: the complexity of targeted inhibitorsNature Rev Cancer200553415415864276
   PubMed Web of Science ®Google Scholar
• JaggiJSKappelBJMcDevittMREfforts to control the errent products of a targeted in vivo generatorCancer Res20056548889515930310
   PubMed Web of Science ®Google Scholar
• JainRKMunnLLFukumuraDDissecting tumor pathophysiology using intravital microscopyNature Rev Cancer200222667612001988
   PubMed Web of Science ®Google Scholar
• JainRKNormalization of tumor vasculature: an emerging concept in antiangiogenic therapyScience2005307586215637262
   PubMed Web of Science ®Google Scholar
• JanssenMOyenWDijkgraafITumor targeting with radiolabeled alpha v beta 3 integrin binding peptides in a nude mouse modelCancer Res20026261465112414640
   PubMed Web of Science ®Google Scholar
• JanssenMFrielinkCDijkgraafIImproved tumor targeting of radiolabeled RGD peptides using rapid dose fractionationCancer Biother Radiopharm20041939940415453954
   PubMed Web of Science ®Google Scholar
• JavidMBrownellGLSweetWHThe possible use of neutron capture isotopes such as boron-10 in the treatment of neoplasms: II. computation of the radiation energy and estimates of effects in normal and neoplastic brainJ Clin Invest19523160310
   Web of Science ®Google Scholar
• JhanwarYSDivgiCCurrent status of therapy of solid tumorsJ Nucl Med200546141s50s15653662
   PubMed Web of Science ®Google Scholar
• JonasdottirTFisherDBorrebaekJFirst in vivo evaluation of liposome-encapsulated 223Ra as a potential alpha-particle-emitting cancer therapeutic agentAnticancer Res2006262841816886603
   PubMed Web of Science ®Google Scholar
• JustusEAwadDHohnholtMSynthesis, liposomal preparation, and in vitro toxicity of two novel dodecaborate cluster lipids for boron neutron capture therapyBioconjugate Chem200718128793
   PubMed Web of Science ®Google Scholar
• KalofonosHRowlinsonGEpenetosAEnhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiationCancer Res199050159632403414
   PubMed Web of Science ®Google Scholar
• KassisAISastryKSRAdelsteinSJKinetics of uptake, retention, and radiotoxicity of I-125 UDR in mammalian cells: implications of localized energy deposition by Auger processesRadiat Res198710978893809393
   PubMed Web of Science ®Google Scholar
• KassisAIThe amazing world of Auger electronsInt J Radiat Biol20048078980315764386
   PubMed Web of Science ®Google Scholar
• KassisAIAdelsteinSJRadiobiologic principles in radionuclide therapyJ Nucl Med2005464s12s15653646
   PubMed Web of Science ®Google Scholar
• KennelSJMirzadehSVascular targeted radioimmunotherapy with 213Bi – an alpha-particle emitterNucl Med Biol19982524169620629
   PubMed Web of Science ®Google Scholar
• KirpotinDBDrummondDCShaoYAntibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal modelsCancer Res20066667324016818648
   PubMed Web of Science ®Google Scholar
• KobayashiHWuCKimM-KEvaluation of the in vivo evaluation of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibodyBioconjugate Chem19991010311
   PubMed Web of Science ®Google Scholar
• KoivunenEWangBRuoslahtiEPhage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RDG-directed integrinsBiotechnology199513265709634769
   PubMed Web of Science ®Google Scholar
• KolbertKSHamacherKAJurcicJGParametric Images of Antibody Pharmacokinetics in Bi213-HuM195 Therapy of LeukemiaJ Nucl Med200142273211197975
   PubMed Web of Science ®Google Scholar
• KolbertKSWatsonTMateiCMurine S factors for liver, spleen, and kidneyJ Nucl Med2003447849112732681
   PubMed Web of Science ®Google Scholar
• KoningGAFretzMMWoronieckaUTargeting liposomes to tumor endothelial cells for neutron capture therapyAppl Radiat Isot200461963715308176
   PubMed Web of Science ®Google Scholar
• KoppeMJPostemaEJAartsFAntibody-guided radiation therapy of cancerCancer Metastasis Rev2005245396716408161
   PubMed Web of Science ®Google Scholar
• KullbergEBWeiQCapalaJEGF-receptor targeted liposomes with boronated acridine: growth inhibition of cultured glioma cells after neutron irradiationInt J Radiat Biol200581621916298943
   PubMed Web of Science ®Google Scholar
• KvolsLKRadiation sensitizers: a selective review of molecules targeting DNA and non-DNA targetsJ Nucl Med200546187s90s15653668
   PubMed Web of Science ®Google Scholar
• LasicDDLiposomes from Physics to Applications1993AmsterdamElsevier
   Google Scholar
• LasicDDMartinFStealth, liposomes1995Boca Raton, FlaCRC Pr
   Google Scholar
• LiC-YShanSHuangQInitial stages of tumor cell-induced angiogenesis: Evaluation via skin window chambers in rodent modelsJ Natl Cancer Inst200092143710639516
   PubMed Web of Science ®Google Scholar
• LiJHuangSArmstrongEAAngiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGF-2) blockadeint J Radiat Oncology Biol Phys200562147785
   PubMed Web of Science ®Google Scholar
• LinGLunderquistAHagerstrandIPostmortem examination of the blood supply and vascular pattern of small liver metastases in manSurgery198496517266474357
   PubMed Web of Science ®Google Scholar
• LindegrenSAnderssonHJacobssonLSynthesis and biodistribution of 211At-labeled, biotinylated, and charge-modified poly-L-lysine: evaluation for use as an effector molecule in pretargeted intraperitoneal tumor therapyBioconjugate Chem2002135029
   Web of Science ®Google Scholar
• LindegrenSKarlssonBJacobssonL211At-labeled and biotinylated effector molecules for pretargeted radioimmunotherapy using poly-L- and poly-D-lysine as multicarriersClin Cancer Res200393873s914506185
   PubMed Web of Science ®Google Scholar
• LindenOKurkusJGarkavijMA novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and 90Y-labeled Rituximab in patients with refractory B-cell lymphomaCancer Biother Radiopharm2005204576616114994
   PubMed Web of Science ®Google Scholar
• LineBRMitraANanATargeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugatesJ Nucl Med20054615526016157540
   PubMed Web of Science ®Google Scholar
• MacklisRMKinseyBMKassisAIRadioimmunotherapy with alpha-particle-emitting immunoconjugatesScience1988240102462897133
   PubMed Web of Science ®Google Scholar
• MaedaHWuJSawaTTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000652718410699287
   PubMed Web of Science ®Google Scholar
• MalikNWiwattanapatapeeRKlopschRRelationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivoJ Control Release2000651334810699277
   PubMed Web of Science ®Google Scholar
• MamedeMSagaTKobayashiHRadiolabeling of avidin with very high specific activity for internal radiation therapy of intraperitoneal disseminated tumorsClin Cancer Res2003937566214506168
   PubMed Web of Science ®Google Scholar
• MantravadiRVPSpigosDGTanWSIntraarterial Yttrium-90 in the treatment of hepatic malignancyRadiolgy19821427836
   Google Scholar
• MaruyamaKIshidaOKasaokaSIntracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT)J Control Release20049819520715262412
   PubMed Web of Science ®Google Scholar
• McDevittMRMaDLaiLTTumor therapy with targeted atomic nanogeneratorsScience200129415374011711678
   PubMed Web of Science ®Google Scholar
• MeredithRFPartridgeEEAlvarezRDIntraperitoneal radioimmunotherapy of ovarian cancer with lutetium-177-CC49J Nucl Med199637149168790200
   PubMed Web of Science ®Google Scholar
• MitraANanAPapadimitriouJCPolymer-peptide conjugates for angiogenesis targeted tumor radiotherapyNucl Med Biol200633435216459258
   PubMed Web of Science ®Google Scholar
• MulfordDAScheinbergDAJurcicJGThe promise of targeted alpha-particle therapyJ Nucl Med200546199s204s15653670
   PubMed Web of Science ®Google Scholar
• MurthyRNunezRSzklarukJYttrium-90 microsphere therapy for hepatic malignancy: Devices, indications, technical considerations, and potential complicationsRadiographics %R 101148/rg25si055515200525S4155
   PubMed Web of Science ®Google Scholar
• NettiPABerkDASwartzMARole of extracellular matrix assembly in interstitial transport in solid tumorsCancer Res200060249750310811131
   PubMed Web of Science ®Google Scholar
• NiederCWiedenmannNAndratschkeNCurrent status of angiogenesis inhibitors combined with radiation therapyCancer Treat Rev2006323486416713103
   PubMed Web of Science ®Google Scholar
• NikulaTKMcDevittMRFinnRDAlpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistryJ Nucl Med199940166769935073
   PubMed Web of Science ®Google Scholar
• NoguchiYWuJDuncanREarly phase tumor accumulation of macromolecules: A great difference between the tumor vs.normal tissue in their clearance rateJpn J Cancer Res199889307149600125
   PubMedGoogle Scholar
• NormannoNDe LucaABiancoCEpidermal growth factor receptor (EGFR) signaling in cancerGene200636621616377102
   PubMed Web of Science ®Google Scholar
• NunezMIVillalobosMOleaNRadiation-induced DNA double-strand break rejoining in human tumour cellsBr J Cancer199571311167841046
   PubMed Web of Science ®Google Scholar
• PaganelliGFerrariMCremonesiMIART(R): Intraoperative avidination for radionuclide treatment. A new way of partial breast irradiationThe Breast200716172617174093
   PubMed Web of Science ®Google Scholar
• PakRHPrimusFJRickard-DicksonKJPreparation and properties of nido-carborane-specific monoclonal antibodies for potential use in boron neutron capture therapy for cancerProc Natl Acad Sci1995926986907624355
   PubMed Web of Science ®Google Scholar
• PalmSEnmonRScheinbergDAModeling alpha-emitter labeled antiPSMA antibody (225Ac-J591) targeting of prostate micrometastases: microdosimetric analysis of spheroid responseCancer Biother Radiopharm200217488
   Google Scholar
• PalmSBackTClaessonITherapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude miceInt J Radiat Oncol Biol Phys200769572917869670
   PubMed Web of Science ®Google Scholar
• PanXQWangHLeeRJBoron delivery to a murine lung carcinoma using folate receptor-targeted liposomesAnticancer Res2002a2216293312168846
   PubMed Web of Science ®Google Scholar
• PanXQWangHShuklaSBoron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapyBioconjugate Chem2002b1343542
   PubMed Web of Science ®Google Scholar
• PattilloCBSari-SarrafFNallamothuRTargeting of the antivascular drug combretastatin to irradiated tumors results in tumor growth delayPharm Res20052211172016028012
   PubMed Web of Science ®Google Scholar
• PaxtonRJBeattyBGVaradarajanACarboranyl peptide-antibody conjugates for neutron-capture therapy: preparation, characterization, and in vivo evaluationBioconjug Chem1992324171520728
   PubMed Web of Science ®Google Scholar
• PohlmanBSweetenhamJMacklisRMReview of clinical radioimmunotherapyExpert Rev Anticancer Ther200664456116503861
   PubMed Web of Science ®Google Scholar
• ReubiJCMaeckeHRKrenningEPCandidates for peptide receptor radiotherapy today and in the futureJ Nucl Med20054667s75s15653654
   PubMed Web of Science ®Google Scholar
• RistoriSOberdisseJGrilloIStructural characterization of cationic liposomes loaded with sugar-based carboranesBiophys J2005885354715489297
   PubMed Web of Science ®Google Scholar
• RogersBEMcLeanSFKirkmanRLIn vivo localization of [111In]-DTPA-D-Phe -Octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vectorClin Cancer Res199953839310037188
   PubMed Web of Science ®Google Scholar
• RogersBEZinnKRLinCYTargeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vectorCancer200294129830511877760
   PubMed Web of Science ®Google Scholar
• RosenLSVEGF-targeted therapy: therapeutic potential and recent advancesOncologist2005103829115967832
   PubMed Web of Science ®Google Scholar
• RuoslathiEPierschbacherMDArg-Gly-Asp: a versatile cell recognition signalCell198644517182418980
   PubMed Web of Science ®Google Scholar
• RuoslathiESpecialization of tumour vasculatureNature Rev Cancer20022839012635171
   PubMed Web of Science ®Google Scholar
• RyanMTPostonJWSA half century of health physics2005Lippincott Williams and Wilkins
   Google Scholar
• SalemRThurstonKGCarrBIYttrium-90 microspheres: Radiation therapy for unresectable liver cancerJ Vasc Interv Radiol200213223S9S
   Web of Science ®Google Scholar
• ScottPAHarrisALCurrent approaches to taargetign cancer using antiangiogenesis therapiesCancer Treat Rev1994203934127525058
   PubMed Web of Science ®Google Scholar
• SgourosGRadiolabeled antibodies, overviewEncyclopedia of Cancer2002Elsevier Science
   Google Scholar
• SgourosGDosimetry of internal emittersJ Nucl Med20054618s27s15653648
   PubMed Web of Science ®Google Scholar
• SgourosGKnoxSJJoinerMCMIRD continuing education: Bystander and low dose-rate effects: Are these relevant to radionuclide therapy?J Nucl Med20074816839117873139
   PubMed Web of Science ®Google Scholar
• SharkeyRMGoldenbergDMPerspectives on cancer therapy with radiolabeled monoclonal antibodiesJ Nucl Med200546115s27s15653660
   PubMed Web of Science ®Google Scholar
• ShuklaSWuGChatterjeeMSynthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapyBioconjugate Chem20031415867
   PubMed Web of Science ®Google Scholar
• SimsDEThe pericyte: a reviewTissue Cell198618153743085281
   PubMed Web of Science ®Google Scholar
• SnyderARReview of radiation-induced bystander effectsHum Exp Toxicol20042387915070066
   PubMed Web of Science ®Google Scholar
• SofouSEnmonRMMcDevittMRMultivesicular radioimmunoliposomes with encapsulated Actinium-225 for targeted alpha-particle therapy of intraperitoneal micrometastatic cancerCancer Biother Radiopharm2004a19s5189
   Web of Science ®Google Scholar
• SofouSThomasJLLinH-YEngineered liposomes for potential α-particle therapy of metastatic cancerJ Nucl Med2004b452536014960644
   PubMed Web of Science ®Google Scholar
• SofouSKappelBJJaggiJSEnhanced retention of the alpha-particle-emitting daughters of actinium-225 by liposome carriersBioconjugate Chem20071820617
   PubMed Web of Science ®Google Scholar
• SofouSSurface-active liposomes for targeted cancer therapyNanomed200727112417976032
   PubMed Web of Science ®Google Scholar
• SøylandCHassfjellSPSurvival of human lung epithelial cells following in vitro alpha-particle irradiation with absolute determination of the number of alpha-particle traversals of individual cellsInt J Radiat Biol20007613152211057739
   PubMed Web of Science ®Google Scholar
• StolzBWeckbeckreGSmith-JonesPMThe somatostatin receptor-targeted radiotherapeutic [90y-DOTA-DPhe1, Tyr3]octreotide (90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumoursEur J Nucl Med199825668749662587
   PubMedGoogle Scholar
• SupiotOGouardSCharrierJMechanisms of cell sensitization to alpha radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell linesClin Cancer Res2005117047s52s16203801
   PubMed Web of Science ®Google Scholar
• SupiotSThillaysFRioEGemcitabine radiosensitizes multiple myeloma cells to low let, but not high let, irradiationRadiother Oncol2007839710117383762
   PubMed Web of Science ®Google Scholar
• ThirumamagalBTSZhaoXBBandyopadhyayaAKReceptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT)Bioconjugate Chem200617114150
   PubMed Web of Science ®Google Scholar
• ThorpePEBurrowsFJAntibody-directed targeting of the vasculature of solid tumorsBreast Cancer Res Treat199536237518534871
   PubMed Web of Science ®Google Scholar
• ThurberGMZajicSCWittrupKDTheoretic criteria for antibody penetration into solid tumors and micrometastasesJ Nucl Med200748995917504872
   PubMed Web of Science ®Google Scholar
• TolpinELWellumGRDohanFCJrBoron neutron capture therapy of cerebral glyomals: II. utilization of the blood-brain barrier and tumor-specific antigens for the selective concentration of boron in gliomasOncology19753222346180470
   PubMed Web of Science ®Google Scholar
• VerschraegenCKumagaiSDavidsonRPhase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato(trans- R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesiclesJ Cancer Res Clin Oncol20031295495514513369
   PubMed Web of Science ®Google Scholar
• WachsbergerPBurdRDickerAPTumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: Exploring mechanisms of InteractionClin Cancer Res2003919577112796357
   PubMed Web of Science ®Google Scholar
• WesterHJKesslerHMolecular targeting with peptides or peptide-polymer conjugates: just a question of size?J Nucl Med2005461940516330555
   PubMed Web of Science ®Google Scholar
• WilburDSPatharePMHamlinDKBiotin reagent for antibody pretargeting. 3. synthesis, radioiodination, and evaluation of biotinylated starburst dendrimersBioconjugate Chem1998981325
   PubMed Web of Science ®Google Scholar
• WongJYCSystemic targeted radionuclide therapy: Potential new areasInt J Radiat Oncol Biol Phys200666S74S8216979445
   PubMed Web of Science ®Google Scholar
• XuFJPirolloKFChangEHTumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapyJ Control Release2001741152811489488
   PubMed Web of Science ®Google Scholar
• XuLYButlerNJMakrigiorgosGMBystander effect produced by radiolabeled tumor cells in vivoProc Natl Acad Sci USA200299137657012368480
   PubMed Web of Science ®Google Scholar
• YinghuaiZPengATCarpenterKSubstituted carborane-appended water-soluble single-wall carbon nanotubes: new approach to boron neutron capture therapy drug deliveryJ Am Chem Soc200512798758015998093
   PubMed Web of Science ®Google Scholar
• ZaidiHSgourosGTherapeutic applications of Monte Carlo calculations in nuclear medicine2003BristolIoP
   Google Scholar
• ZamenhofRGMicrodosimetry for boron neutron capture therapy: a reviewJ Neurooncol19973381929151226
   PubMed Web of Science ®Google Scholar
• ZhangJ-SLiuFHuangLImplications of pharmacokinetic behavior of lipoplex for its inflammatory toxicityAdv Drug Deliv Rev2005576899815757755
   PubMed Web of Science ®Google Scholar
• ZnatiCARosensteinMMcKeeTDIrradiation reduces interstitial fluid transport and increases collagen content in tumorsClin Cancer Res2003955081314654530
   PubMed Web of Science ®Google Scholar